Antacids in gastric ulcer treatment: evidence of cytoprotection

Scand J Gastroenterol Suppl. 1990:174:44-7. doi: 10.3109/00365529009091929.

Abstract

Antacids are more effective than placebo, and their efficacy is comparable to that of H2-blockers in gastric ulcer healing even though the healing time is about 2 weeks longer than with H2-blockers. Some observations in animals and healthy subjects may indicate that antacids (particularly those containing aluminium hydroxide) have a protective effect on the gastroduodenal mucosa in that they increase the production of prostanoids and sulphydryl-containing compounds. We showed that 10 days' treatment with high-dose antacids (Maalox TC) is able to increase 6-keto-PGF1 alpha production from cultured biopsy specimens of patients with gastric ulcer. These data could constitute a further indication in the treatment of peptic disease.

Publication types

  • Review

MeSH terms

  • Aluminum Hydroxide / therapeutic use
  • Animals
  • Antacids / therapeutic use*
  • Drug Combinations / therapeutic use
  • Gastric Mucosa / drug effects*
  • Gastric Mucosa / physiology
  • Humans
  • Magnesium Hydroxide / therapeutic use
  • Stomach Ulcer / drug therapy*
  • Time Factors

Substances

  • Antacids
  • Drug Combinations
  • aluminum hydroxide, magnesium hydroxide, drug combination
  • Aluminum Hydroxide
  • Magnesium Hydroxide